Acquisition

06th October, 2026 To, To, The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange (NSE), Phiroze Jheejheebhoy Towers, Exchange Plaza, Dalal Street, 5th Floor Plot No.C/1, 'G' Block Mumbai - 400 001. Bandra - Kurla Complex Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS Dear Sir/ Madam Sub: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Acquisition of upto 51% Equity Stake in Insignia Healthcare Private Limited (KIMS-SIKHARA), an O & M entity – Reg. Pursuant to provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of Krishna Institute of Medical Sciences Limited (“the Company”) at its meeting held on today, i.e. 06th October, 2026 has approved the proposal for acquisition of upto 51% equity stake of the total paid-up equity share capital of Insignia Healthcare Private Limited (KIMS-SIKHARA), an O & M entity. We enclose herewith the details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, as Annexure-1 to this letter. Kindly take the above intimation on your records. This intimation is also uploaded on the Company’s website at: https://www.kimshospitals.com/investors/ > Disclosures under Regulation 62 of the SEBI (LODR) Regulations, 2015 > Intimations filed by the Company > Intimations under Regulation 30. Thanking You, Yours truly For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary and Compliance Officer ANNEXURE -1 a Name of the target entity, details in brief Name of the target entity: Insignia Healthcare such as size, turnover, etc., Private Limited. Details in brief: Insignia Healthcare Private Limited (the Company), a company incorporated under the laws of India and having its registered office at 15-11-33, Mangalagirri Road, Near Bestprice, Mangaldas Nagar, Guntur – 522001, Andhra Pradesh, carrying on the business of providing hospital services. Insignia Healthcare Private Limited has constructed the Hospital and is operating, a 150-bed hospital with the potential to increase the capacity to 200-bed with the latest medical infrastructure, medical and diagnostic equipment, and multiple operation theatres. In order to operate and manage the Hospital more efficiently and effectively, the Company requires the services of a specialist and professional team of experts. In light of this, the Company has engaged and appointed the KIMS to exclusively manage and operate the Hospital and to provide various Medical Services and if required, additional Medical Services, at the Hospital with the help of the required infrastructure and experienced and competent surgeons/ clinicians and physicians. (Rs. in Crore) FY 2024-25 Turnover: 9.68 PAT: -13.28 Networth: 243.3 b Whether the acquisition would fall within Acquisition of equity shares does not fall within related party transaction(s) and whether the definition of Related Party Transaction. the promoter / promoter group / group companies have any interest in the entity being acquired? If yes, nature of Interest and details thereof and whether the same is done at "Arms length": c Industry to which the entity being acquired Healthcare Industry belongs: d Objects and effects of acquisition (including KIMS, being the O & M Partner of the target entity but not limited to, disclosure of reasons for has decided to acquire upto 51% of the total equity acquisition of target entity, if its business is stake as a strategic investment, by way of creeping acquisition over an indicative time period. outside the main line of business of the listed entity e Brief details of any governmental or regulatory Not Applicable. approvals required for the acquisition: f Indicative time period for completion of the Within a period of 12 to 24 Months. acquisition g Consideration - whether cash consideration Cash. or share swap and details of the same: h Cost of acquisition or the price at which the The shares will be acquired at Rs. 30.35/- per shares are acquired; equity share, based on the valuation report issued by BDO Valuation Advisory LLP dated 05th October, 2026, subsequent acquisition shall be at cost based on the valuation report from an independent valuer. i Percentage of shareholding/control KIMS will acquire upto 51.00% of the equity share acquired and/or number of shares capital of Target Company on fully diluted basis. acquired; j Brief background about the entity acquired Brief background about the entity acquired: As in terms of products/line of business mentioned in serial no. (a) acquired, date of incorporation, history of last 3 years turnover, country in which the Date of Incorporation: 02-07-2018 acquired entity has presence, and any other significant information (in brief): History of last 3 years Total Turnover of the Company: Particulars Amount in Crores FY25 104.5 FY24 0.09 FY23 - Presence: Guntur, Andhra Pradesh - India Other Significant Information: please refer to the aforementioned.